• 1
    Anderson FA, Wheeler HB, Goldberg RJ et al. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1991; 151: 93338.
  • 2
    Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. Br Med J 1991; 302: 70911.
  • 3
    Hirsh J, Salzman EW, Marder Vj. Treatment of venous thromboembolism. In: ColmanRW, HirshJ, MarderVJ, SalzmanEW, eds. Hemostasis and Thrombosis Basic Principles and Clinical Practice, 3rd edn. Philadelphia: J.B.Lippincott, 1994.
  • 4
    Hyers TM, Hull RD, Weg Gj. Antithrombotic therapy for venous thromboembolic disease. Chest 1998; 114: 56178S.
  • 5
    Ten Cate JW, Koopman MM, Prins MH, Buller Hr. Treatment of venous thromboembolism Thromb Haemost 1995; 74: 197203.
  • 6
    Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Circulation 1996; 93: 221245.
  • 7
    Ginsberg Js. Management of venous thromboembolism. New Engl J Med 1996; 335: 181628.
  • 8
    Hirsh J. The optimal duration of anticoagulant therapy for venous thrombosis. New Engl J Med 1995; 332: 171011.
  • 9
    Diuguid Dl. Oral anticoagulant therapy for venous thromboembolism. New Engl J Med 1997; 336: 43334.
  • 10
    Hirsh J, Kearon C, Ginsberg J. Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. Arch Int Med 1997; 157: 217476.
  • 11
    Bounameaux H, De Moerloose P, Sarasin Fp. Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs. Blood Coag Fibrinol 1996; 7: 50714.
  • 12
    Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P and the Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New Engl J Med 1995; 332: 166165.
  • 13
    Prandoni P, Lensing AW, Cogo A et al. The long term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 17.
  • 14
    Research Committee of the British Thoracic Society (Campbell IA). Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet 1992; 340: 87376.
  • 15
    Levine MN, Hirsh J, Gent M et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 60611.
  • 16
    Palareti G, Leali N, Coccheri S, et al. on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy. Bleeding complications of oral anticoagulant treatment: an inception cohort prospective collaboration study (ISCOAT). Lancet 1996; 348: 42328.
  • 17
    Van Der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 155762.
  • 18
    Landefeld CS, Beyth Rj. Anticoagulant related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993; 95: 31528.
  • 19
    Fihn SD, Mc Donell M, Martin D et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Ann Intern Med 1993; 118: 51120.
  • 20
    Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Phil D, Silverstein Md. Bleeding and thromboembolism during anticoagulant therapy. A population based study in Rochester Minnesota. Mayo Clin Proc 1995; 70: 72533.
  • 21
    Pineo GF, Hull Rd. Prevention and treatment of venous thromboembolism. Drugs 1996; 52: 7192.
  • 22
    Kearon C. Drug trials that have influenced our practice in the treatment of venous thromboembolism. Thromb Haemost 1997; 78: 55357.
  • 23
    O'sullivan Ef. Duration of anticoagulant therapy in venous thromboembolism. Med J Aust 1972; 2: 1104107.
  • 24
    Schulman S, Lockner D, Juhlin Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis: a randomized study. Acta Med Scand 1985; 217: 54752.
  • 25
    Holmgren KA, Andersson G, Fagrell B. One-month versus six months therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Med Scand 1985; 218: 27984.
  • 26
    Fennerty AG, Dolben J, Thomas P et al. A comparison of 3 and 6 weeks anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol 1987; 9: 1721.
  • 27
    Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New Engl J Med 1999; 340: 901907.
  • 28
    Cucherat M, Boissel JP, Leizorovicz A, Haugh Mc. Easy MA: a program for the meta-analysis of clinical trials. Computer Methods Prog Biomed 1997; 53: 18790.
  • 29
    Fennerty AG, Campbell IA, Routledge Pa. Anticoagulants in venous thromboembolism. Guidelines for optimum treatment. Br Med J 1988; 297: 128588.
  • 30
    Fleiss Jl. Determining sample sizes needed to detect a difference between two proportions.In: Statistical Methods for Rates and Proportions, 2nd edn. New York: Wiley, 1981; 3349
  • 31
    Pinède L, Ninet J, Boissel JP, Pasquier J. Traitement anticoagulant pour maladie thrombo-embolique veineuse: durée optimale de prescription des Antivitamines-K. Revue de la littérature. Presse Med 1994; 23: 181720.